Login to Your Account



FDA Panel Votes In Favor Of Biogen's Amevive For Psoriasis

By Kim Coghill


Friday, May 24, 2002
SILVER SPRING, Md. - A panel of experts advising the FDA recommended approval of Biogen Inc.'s psoriasis drug Amevive on Thursday. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription